← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN · Approved 2016-01-07

Drug application

FDA Application #

ANDA205429

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

Dapsone

Active ingredients

DAPSONE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ALVOGEN

First approval

2016-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown